SUBSCRIBE
SUBSCRIBE

Agenus Inc.

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Genetown
Agenus Trades Away Future Royalties on Sales of GlaxoSmithKline Drug for $115 Million
September 9, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Incyte Corporation, Agenus Strike $410 Million+ Immuno-Oncology Antibodies Pact
January 9, 2015
 · 
2 min read
Load More
JOBS
IN THE PRESS
Drug Development
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
May 16, 2024
 · 
4 min read
Business
Agenus Reports First Quarter 2024 Results
May 7, 2024
 · 
9 min read
BioMidwest
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
May 7, 2024
 · 
11 min read
Deals
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 1, 2024
 · 
1 min read
Genetown
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
April 24, 2024
 · 
4 min read
Business
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
April 23, 2024
 · 
2 min read
Genetown
SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant
April 17, 2024
 · 
2 min read
Drug Development
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
April 12, 2024
 · 
3 min read
Business
Agenus Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024
 · 
10 min read
Genetown
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
March 6, 2024
 · 
4 min read
Load More